SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Kannaway, LLC the hemp lifestyle network marketing firm, and subsidiary of Medical Marijuana Inc (OTCMKTS:MJNA) educated thousands of people through the its support of CANCERSTOCK San Diego. The educational session was carried on April 11. It was more of a one-day music and health festival held at the Moonlight Amphitheatre in Vista.

The expert view

Jeff Rogers, who is the CEO of Medical Marijuana’s Kannaway, said that the management fees proud to have supported ‘CANCERSTOCK San Diego’, Sons of Charity and the local families. The event is expected to have a direct positive impact on the company. It was a great opportunity to associate with community and industry leaders while pursuing the initiative of enhancing the public’s awareness of daily products that have hemp CBD oil. The company congratulated CANCERSTOCK on a successful launch and looks forward to associate with the organization at upcoming events.

The expansion

Medical Marijuana Inc (OTCMKTS:MJNA) subsidiary firm Wellness Managed Services’ MPSI is a known name in offering security services for the developing cannabis market. Recently, it stated that it obtained exclusive security contracts for historic events including Seattle Hempfest. It even obtained a security contract for “420” week to be held in Colorado.

The impact

Friday’s trading session witnessed Medical Marijuana close in green. It posted gains of more than 1% to close the day at $0.0860. It was the second consecutive day of gains after touching a 52 week low of $0.06 a share in previous trading session. The stock generated daily volume of 3.07 million compared to average daily volume of 3.34 million. The stock was trading in oversold zone and therefore, investors expected a mild pullback. Medical Marijuana is trading under pressure as it has still not issued its annual report. The company previously announced that it will release the report by the end of March.